According to CONMED's latest financial reports the company's current EPS (TTM) is -$3.21. In 2022 the company made an earnings per share (EPS) of -$2.76 a decrease over its 2021 EPS that were of $2.14.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.21 | 16.3% |
2022 | -$2.76 | -228.97% |
2021 | $2.14 | 548.48% |
2020 | $0.33 | -67.65% |
2019 | $1.02 | -30.14% |
2018 | $1.46 | -26.63% |
2017 | $1.99 | 282.69% |
2016 | $0.52 | -52.73% |
2015 | $1.10 | -6.78% |
2014 | $1.18 | -9.23% |
2013 | $1.30 | -9.09% |
2012 | $1.43 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $4.84 | -250.82% | ๐บ๐ธ USA |
![]() Medtronic MDT | $3.05 | -195.02% | ๐ฎ๐ช Ireland |
![]() Boston Scientific BSX | $0.59 | -118.38% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $6.93 | -315.89% | ๐บ๐ธ USA |
![]() Teleflex TFX | $7.73 | -340.81% | ๐บ๐ธ USA |
![]() Integra LifeSciences IART | $2.07 | -164.35% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | $1.12 | -134.95% | ๐ฌ๐ง UK |